MAPT and Alzheimer disease: HDAC inhibition has been described as a promising therapeutic strategy offering neuroprotection by reversing hypoacetylation in AD, preventing Aβ-induced tau hyperphosphorylation, and promoting genes related to synaptic plasticity, learning, and memory21.